+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Needle Free Drug Delivery Device Market Research Report by Technology, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968741
  • Report
  • October 2021
  • Region: Global
  • 180 pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Needle Free Drug Delivery Device Market is Projected to Reach USD 18,191.17 Million by 2026, Registering a CAGR of 15.08%

FEATURED COMPANIES

  • 3M
  • AkraDermojet Inc
  • Antares Pharma Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • InjexPharma AG
  • MORE
The Global Needle Free Drug Delivery Device Market size was estimated at USD 7,831.70 million in 2020, is expected to reach USD 8,986.24 million in 2021, and projected to grow at a CAGR of 15.08% reaching USD 18,191.17 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Needle Free Drug Delivery Device to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Technology, the market was studied across Inhaler Technology, Jet Injectors, Novel Needle-free Technologies, Oral Drug Delivery System, and Transdermal Patch Technology.
  • Based on Application, the market was studied across Insulin Delivery for Diabetes, Pain Management, Pediatric Injections, and Vaccine Delivery.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Needle Free Drug Delivery Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Needle Free Drug Delivery Device Market, including 3M, AkraDermojet Inc, Antares Pharma Inc., Bayer AG, Bioject Medical Technologies, Inc., GlaxoSmithKline plc, Glide Pharmaceutical Technologies Ltd., InjexPharma AG, Medtronic, Inc., and Zogenix, Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Needle Free Drug Delivery Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Needle Free Drug Delivery Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Needle Free Drug Delivery Device Market?
4. What is the competitive strategic window for opportunities in the Global Needle Free Drug Delivery Device Market?
5. What are the technology trends and regulatory frameworks in the Global Needle Free Drug Delivery Device Market?
6. What is the market share of the leading vendors in the Global Needle Free Drug Delivery Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Needle Free Drug Delivery Device Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M
  • AkraDermojet Inc
  • Antares Pharma Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • InjexPharma AG
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing need for self-administration of high viscous drug into the body
5.2.2. Rising number of chronic diseases such as diabetes globally
5.2.3. Growing focus to curb the spread of infectious diseases such as hepatitis and AIDS
5.3. Restraints
5.3.1. High development cost compared to conventional injection system
5.4. Opportunities
5.4.1. Rapid technological advancement in the field of pain-free drug transportation
5.4.2. Introduction of technologically advanced products such as insulin pen, insulin pump, and other devices
5.5. Challenges
5.5.1. Availability of alternative modes of drug delivery and requires sterility system maintenance

6. Needle Free Drug Delivery Device Market, by Technology
6.1. Introduction
6.2. Inhaler Technology
6.3. Jet Injectors
6.4. Novel Needle-free Technologies
6.5. Oral Drug Delivery System
6.6. Transdermal Patch Technology

7. Needle Free Drug Delivery Device Market, by Application
7.1. Introduction
7.2. Insulin Delivery for Diabetes
7.3. Pain Management
7.4. Pediatric Injections
7.5. Vaccine Delivery

8. Americas Needle Free Drug Delivery Device Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Needle Free Drug Delivery Device Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Needle Free Drug Delivery Device Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 3M
12.2. AkraDermojet Inc.
12.3. Antares Pharma Inc.
12.4. Bayer AG
12.5. Bioject Medical Technologies, Inc.
12.6. GlaxoSmithKline plc
12.7. Glide Pharmaceutical Technologies Ltd.
12.8. InjexPharma AG
12.9. Medtronic, Inc.
12.10. Zogenix, Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
Figure 1. Global Needle Free Drug Delivery Device Market Size, 2020 vs 2026 (USD Million)
Figure 2. Global Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 3. Global Needle Free Drug Delivery Device Market: Market Dynamics
Figure 4. Global Needle Free Drug Delivery Device Market Size, by Technology, 2020 vs 2026 (%)
Figure 5. Global Needle Free Drug Delivery Device Market Size, by Technology, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for Global Needle Free Drug Delivery Device Market Size, by Technology, 2026
Figure 7. Global Needle Free Drug Delivery Device Market Size, by Inhaler Technology, 2018-2026 (USD Million)
Figure 8. Global Needle Free Drug Delivery Device Market Size, by Inhaler Technology, by Region, 2020 vs 2026 (USD Million)
Figure 9. Global Needle Free Drug Delivery Device Market Size, by Jet Injectors, 2018-2026 (USD Million)
Figure 10. Global Needle Free Drug Delivery Device Market Size, by Jet Injectors, by Region, 2020 vs 2026 (USD Million)
Figure 11. Global Needle Free Drug Delivery Device Market Size, by Novel Needle-Free Technologies, 2018-2026 (USD Million)
Figure 12. Global Needle Free Drug Delivery Device Market Size, by Novel Needle-Free Technologies, by Region, 2020 vs 2026 (USD Million)
Figure 13. Global Needle Free Drug Delivery Device Market Size, by Oral Drug Delivery System, 2018-2026 (USD Million)
Figure 14. Global Needle Free Drug Delivery Device Market Size, by Oral Drug Delivery System, by Region, 2020 vs 2026 (USD Million)
Figure 15. Global Needle Free Drug Delivery Device Market Size, by Transdermal Patch Technology, 2018-2026 (USD Million)
Figure 16. Global Needle Free Drug Delivery Device Market Size, by Transdermal Patch Technology, by Region, 2020 vs 2026 (USD Million)
Figure 17. Global Needle Free Drug Delivery Device Market Size, by Application, 2020 vs 2026 (%)
Figure 18. Global Needle Free Drug Delivery Device Market Size, by Application, 2020 vs 2026 (USD Million)
Figure 19. Competitive Strategic Window for Global Needle Free Drug Delivery Device Market Size, by Application, 2026
Figure 20. Global Needle Free Drug Delivery Device Market Size, by Insulin Delivery for Diabetes, 2018-2026 (USD Million)
Figure 21. Global Needle Free Drug Delivery Device Market Size, by Insulin Delivery for Diabetes, by Region, 2020 vs 2026 (USD Million)
Figure 22. Global Needle Free Drug Delivery Device Market Size, by Pain Management, 2018-2026 (USD Million)
Figure 23. Global Needle Free Drug Delivery Device Market Size, by Pain Management, by Region, 2020 vs 2026 (USD Million)
Figure 24. Global Needle Free Drug Delivery Device Market Size, by Pediatric Injections, 2018-2026 (USD Million)
Figure 25. Global Needle Free Drug Delivery Device Market Size, by Pediatric Injections, by Region, 2020 vs 2026 (USD Million)
Figure 26. Global Needle Free Drug Delivery Device Market Size, by Vaccine Delivery, 2018-2026 (USD Million)
Figure 27. Global Needle Free Drug Delivery Device Market Size, by Vaccine Delivery, by Region, 2020 vs 2026 (USD Million)
Figure 28. Americas Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 29. Argentina Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 30. Brazil Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 31. Canada Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 32. Mexico Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 33. United States Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 34. Asia-Pacific Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 35. Australia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 36. China Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 37. India Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 38. Indonesia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 39. Japan Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 40. Malaysia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 41. Philippines Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 42. Singapore Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 43. South Korea Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 44. Taiwan Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 45. Thailand Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 46. Europe, Middle East & Africa Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 47. France Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 48. Germany Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 49. Italy Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 50. Netherlands Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 51. Qatar Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 52. Russia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 53. Saudi Arabia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 54. South Africa Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 55. Spain Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 56. United Arab Emirates Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 57. United Kingdom Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Figure 58. Global Needle Free Drug Delivery Device Market: FPNV Positioning Matrix
Figure 59. Global Needle Free Drug Delivery Device Market: Share, by Key Player, 2020
Figure 60. Competitive Scenario Analysis in Global Needle Free Drug Delivery Device Market, by Type

List of Tables
Table 1. Global Needle Free Drug Delivery Device Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 4. Global Needle Free Drug Delivery Device Market Size, by Technology, 2018-2026 (USD Million)
Table 5. Global Needle Free Drug Delivery Device Market Size, by Inhaler Technology, by Region, 2018-2026 (USD Million)
Table 6. Global Needle Free Drug Delivery Device Market Size, by Jet Injectors, by Region, 2018-2026 (USD Million)
Table 7. Global Needle Free Drug Delivery Device Market Size, by Novel Needle-Free Technologies, by Region, 2018-2026 (USD Million)
Table 8. Global Needle Free Drug Delivery Device Market Size, by Oral Drug Delivery System, by Region, 2018-2026 (USD Million)
Table 9. Global Needle Free Drug Delivery Device Market Size, by Transdermal Patch Technology, by Region, 2018-2026 (USD Million)
Table 10. Global Needle Free Drug Delivery Device Market Size, by Application, 2018-2026 (USD Million)
Table 11. Global Needle Free Drug Delivery Device Market Size, by Insulin Delivery for Diabetes, by Region, 2018-2026 (USD Million)
Table 12. Global Needle Free Drug Delivery Device Market Size, by Pain Management, by Region, 2018-2026 (USD Million)
Table 13. Global Needle Free Drug Delivery Device Market Size, by Pediatric Injections, by Region, 2018-2026 (USD Million)
Table 14. Global Needle Free Drug Delivery Device Market Size, by Vaccine Delivery, by Region, 2018-2026 (USD Million)
Table 15. Americas Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 16. Argentina Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 17. Brazil Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 18. Canada Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 19. Mexico Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 20. United States Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 21. Asia-Pacific Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 22. Australia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 23. China Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 24. India Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 25. Indonesia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 26. Japan Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 27. Malaysia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 28. Philippines Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 29. Singapore Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 30. South Korea Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 31. Taiwan Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 32. Thailand Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 33. Europe, Middle East & Africa Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 34. France Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 35. Germany Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 36. Italy Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 37. Netherlands Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 38. Qatar Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 39. Russia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 40. Saudi Arabia Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 41. South Africa Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 42. Spain Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 43. United Arab Emirates Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 44. United Kingdom Needle Free Drug Delivery Device Market Size, 2018-2026 (USD Million)
Table 45. Global Needle Free Drug Delivery Device Market: Scores
Table 46. Global Needle Free Drug Delivery Device Market: Business Strategy
Table 47. Global Needle Free Drug Delivery Device Market: Product Satisfaction
Table 48. Global Needle Free Drug Delivery Device Market: Ranking
Table 49. Global Needle Free Drug Delivery Device Market: Share, by Key Player, 2020
Table 50. Global Needle Free Drug Delivery Device Market: Merger & Acquisition
Table 51. Global Needle Free Drug Delivery Device Market: Agreement, Collaboration & Partnership
Table 52. Global Needle Free Drug Delivery Device Market: New Product Launch & Enhancement
Table 53. Global Needle Free Drug Delivery Device Market: Investment & Funding
Table 54. Global Needle Free Drug Delivery Device Market: Award, Recognition & Expansion
Table 55. Global Needle Free Drug Delivery Device Market: License & Pricing
Note: Product cover images may vary from those shown
  • 3M
  • AkraDermojet Inc
  • Antares Pharma Inc.
  • Bayer AG
  • Bioject Medical Technologies, Inc.
  • GlaxoSmithKline plc
  • Glide Pharmaceutical Technologies Ltd.
  • InjexPharma AG
  • Medtronic, Inc.
  • Zogenix, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll